ADAM OLSON: Open Payments
NPI 1285499699 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 36 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $123 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $181 |
| Novo Nordisk Inc | 4 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Electromed, Inc. | 1 | $40 |
| Abbott Laboratories | 2 | $38 |
| ABIOMED | 1 | $35 |
| Boston Scientific Corporation | 1 | $34 |
| Seqirus USA Inc | 1 | $33 |
Products named: VRAYLAR, UBRELVY, Ozempic, TRINTELLIX, REXULTI, SMARTVEST, WATCHMAN FLX, Flucelvax.
Industry payments across TN — which companies pay providers there.
